Comparing the effect of only bolus Eptifibatide with bolus plus infusion form of Eptifibatide on bleeding complications and consequences on myocardial infarct patients

Not Applicable

• Conditions: myocardial infarction.; E1, E2, E3, E4, E9

• Registration Number: IRCT2017071935183N1
• Lead Sponsor: isfahan university of medical science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 176

Inclusion Criteria

Inclusion criteria were as followed: 1) age more than 18 years, 2)having elevation in Troponin enzyme level, 3) having electrocardiogram changes due to infarction, 4)candidate for angioplasty and percutaneous coronary intervention, 5) having no contraindication for administrating Eptifibatide, 6) patient's willingness to participate in this study
Exclusion criteria were as followed:1) Patient's unwillingness to continue his/ her participation, 2)history of stroke, 3)treating with anti coagulant medications, 4)using medications that has interaction with Eptifibatide, 5) have not experience PCI, 6)have experienced thrombectomy, 7) having sensitivity to Eptifibatide, 8) having uncontrolled hypertension, 9) dialysis patients

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of hematoma. Timepoint: immediately after intervention, 24, 48,72 and 96 hours after intervention. Method of measurement: observation.;Incidence of bleeding. Timepoint: immediately after intervention, 24, 48,72 and 96 hours after intervention. Method of measurement: observation.

Secondary Outcome Measures

Name	Time	Method
eeds for additional coronary intervention. Timepoint: one week after intervention. Method of measurement: physical examination.;Death. Timepoint: one week after intervention. Method of measurement: observation.